GE Healthcare (Chalfont, UK) has been making notable moves toward fighting cancer for some time now, and the latest product offering from the company shows that GE has not lost sight of that important focus. The company reported that Clarient Diagnostic Services (Aliso Viejo, California), a GE Healthcare company, will begin offering a next-generation sequencing assay focused on solid tumor targets for use in clinical trials.